Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy

NCT00817063 is registered in ClinicalTrials.gov with Stiefel, a GSK Company as lead sponsor.

NCT NCT00817063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00817063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Lead sponsor
Stiefel, a GSK Company
Phase
Phase 3
Overall status
Completed
Start date
January 8, 2009
Completion date
April 26, 2012
Enrollment
599 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

eczema